India's Pharma Story: Preparing For The Next Leap

24 - 25 March 2022
AI Partner
AI Partner - Healthplix
Supporting Partner
Supporting Partner - AHPI
 
Supporting Partner
Supporting Partner - IDMA

Overview

According to a GlobalData survey, 35% of pharmaceutical industry professionals believe that the COVID-19 pandemic has speeded up digital transformation in the pharmaceutical industry by more than five years. Industry experts believe that apart from virtual interactions, technology has helped Indian Pharma in training and connecting doctors with global experts for knowledge sharing and this trend is poised to continue in the years to come as well. However, there are new pressure points building for the pharma industry now. This is largely triggered by the rise in price of raw material and API (active pharmaceutical ingredients or drug ingredients) apart from snarled supply chain. According to IDMA, industry has been facing a huge cost escalation due to imported raw materials and excipients - in some cases a very high increase in prices. While this is a challenge the Indian pharma has to deal with at the moment, the key ask of the industry is to be able to move from being the pharmacy of the world to emerging as an innovation hub. The FE Pharma Summit will bring together key stakeholders, to discuss what the industry needs to do to progress on this journey and what role can the government play to be an enabler. Also, being discussed, would be the role that technology can play in this. How do they look at the advances in drug discovery, nano technology and other areas and get the thought leaders to debate on finding effective and sustainable development of the industry. Some argue that sustainable manufacturing or green manufacturing may be one way to deal with competition from China. Finally, there is the aspect of the ever-changing regulatory scenario. What some of the newer provisions could mean for the industry and the way ahead.

Recorded Sessions

  • Day-1: From Pharmacy of the World to Being its Innovation Hub

  • Day-2: Indian Pharma: The Opportunity In Adversity Story

Key Discussion Points

DAY 1 - From pharmacy of the world to being its innovation hub

  • Pharma story: Preparing for the next leap
  • Digital First Approach in Pharma : Expectations vs Reality
  • The future of doctors' connect : Leveraging Data for actionable insights
  • Regulations & Compliances: Creating Digital Strategies within the established framework
  • Cloud on the horizon: A must for Pharma Manufacturing's big leap?
  • Drug Discovery and Drug Repurposing: How technology changes the game

DAY 2 - Indian Pharma : Coping with newer challenges & the emerging opportunities

  • Creating global scale and impact with APIs
  • Analysts' View on Indian Pharma Market : Challenges and Opportunities
  • Workforce agility and upskilling: A must-have upgrade
  • Sales & Marketing Over R&D : The rights and wrongs
  • CDMOs: An imperative in Indian pharma's growth journey specially leveraging the China plus one strategy of global companies for sourcing?
  • India's Vaccine Game - COVID and beyond
  • Rare Diseases' Treatment: Despite challenges, how pharma companies can play a pivotal role

WHY ATTEND?

  • 2 Full Days of Networking

  • 10+ Knowledgeable Sessions

  • 50+ Speakers

  • 1000+ Delegates

 

Our Speakers

Anil Pareek

President Medical Affairs & Clinical Research
Ipca Labs

Chaitanya Raju

Chief of AI
HealthPlix

Dilip Shanghvi

Managing Director
Sun Pharma

D R Gahane

Joint Commissioner
Food and Drug Administration
Government of Maharastra

Farhat Umar

President-Global Human Resources
MANKIND PHARMA LTD

Glenn Saldanha

Chairman & Managing Director
Glenmark Pharmaceuticals

Hemant G Koshia

Commissioner, Food and Drug Control Administration
Government of Gujarat

Jaby Jacob

Senior President - R&D,
Bharat Serums and Vaccines

Jaspreet Singh

Partner & National Leader – Client and Markets (Technology and Transformation), Grant Thornton Bharat LLP

Kalyan Mangalapalli

Director
NASSCOM Centre of Excellence IoT & AI , Healthcare

Kiran Mazumdar Shaw

Founder
Biocon Limited

Krishna Prasad Chigurupati

Chairman and Managing Director
Granules India

Krishna Sai T

Associate Vice President IT
Biocon

Madhukar Gangadi

CEO
Medplus India

Nikhil Chopra

CEO
JB Chemicals

P Jayakumar

CEO
Apollo Pharmacy

Pankaj Patel

Chairman
Zydus Group

Prateek Verma

Vice President and
Head ePharmacy
Tata 1mg

Dr Ramaiah Muthyala

President & CEO
Indian Organization for Rare Diseases

Rehan A Khan

Managing Director, India Region
MSD

S Aparna

Secretary
Government of India

Dr. S.Eswara Reddy

Joint Drugs Controller (India)
Central Drugs Standard Control Organization

Dr. Satyanarayana Chava

Founder and CEO
Laurus Labs

Shirish G Belapure

Senior Technical Advisor
Indian Pharmaceutical Alliance

Sridhar Bharadwaj

Vice President Human Resources
J.B. Chemicals & Pharmaceuticals Limited

Sudarshan Jain

Secretary-General
Indian Pharmaceutical Alliance

Tushar Zade

CIO & CDO
Aurigene Pharmaceutical Services Limited

Umesh Mehta

EVP and Global CIO
Jubilant Life Sciences

V Simpson Emmanuel

MD and CEO
Roche India

Who Should Attend

  • Pharma Chairman, promoters & CEOs
  • Policy makers, regulatory officials and government officials
  • R&D lab and Drug Development Heads
  • API Development Heads
  • Pharma Packaging & Labelling Heads
  • Supply Chain & Logistics Heads
  • Pharma Facility Managers and Procurement Officials
  • Pharma Equipment Suppliers & Distributors
  • Hospital Administrators
  • CIOs, CTOs from Pharma Companies
  • Pharma Technology companies
  • Packaging, Labelling & Risk Solutions Companies
  • Top Office Bearers from Apex Industry Associations

Contact Us

For Partnerships, Alliances and Speaking Opportunity

Diksha Gupta
diksha.gupta@financialexpress.com
+91 9717854520